| Current management practices for acromegaly: an international survey. | |
| | |
MedLine Citation:
|
PMID: 21063787 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
To determine whether peer-reviewed consensus statements have changed clinical practice, we surveyed acromegaly care in specialist centers across the globe, and determined the degree of adherence to published consensus guidelines on acromegaly management. Sixty-five acromegaly experts who participated in the 7th Acromegaly Consensus Workshop in March 2009 responded. Results indicated that the most common referring sources for acromegaly patients were other endocrinologists (in 26% of centers), neurosurgeons (25%) and primary care physicians (21%). In sixty-nine percent of patients, biochemical diagnoses were made by evaluating results of a combination of growth hormone (GH) nadir/basal GH and elevated insulin like growth factor-I (IGF-I) levels. In both Europe and the USA, neurosurgery was the treatment of choice for GH-secreting microadenomas and for macroadenomas with compromised visual function. The most widely used criteria for neurosurgical outcome assessment were combined measurements of IGF-I and GH levels after oral glucose tolerance test (OGTT) 3 months after surgery. Ninety-eight percent of respondents stated that primary treatment with somatostatin receptor ligands (SRLs) was indicated at least sometime during the management of acromegaly patients. In nearly all centers (96%), the use of pegvisomant monotherapy was restricted to patients who had failed to achieve biochemical control with SRL therapy. The observation that most centers followed consensus statement recommendations encourages the future utility of these workshops aimed to create uniform management standards for acromegaly. |
| | |
Authors:
|
A Giustina; M D Bronstein; F F Casanueva; P Chanson; E Ghigo; K K Y Ho; A Klibanski; S Lamberts; P Trainer; S Melmed |
Related Documents
:
|
313117 - Simple innocuous treatment of massive cyclophosphamide hemorrhagic cystitis. 19385537 - Arthroscopic management of femoroacetabular impingement. 10863457 - Managing the endodontic patient with disabling anxiety or phobia. 15772137 - Nurse-led management of uncomplicated cellulitis in the community: evaluation of a prot... 18312497 - Withanolide a is inherently de novo biosynthesized in roots of the medicinal plant ashw... 18981427 - The sackler colloquium on promises and perils in nanotechnology for medicine. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Pituitary Volume: 14 ISSN: 1573-7403 ISO Abbreviation: Pituitary Publication Date: 2011 Jun |
Date Detail:
|
Created Date: 2011-05-16 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9814578 Medline TA: Pituitary Country: United States |
Other Details:
|
Languages: eng Pagination: 125-33 Citation Subset: IM |
Affiliation:
|
Department of Medical and Surgical Sciences, University of Brescia, Endocrine Service, Montichiari Hospital, Via Ciotti 154, 25018, Montichiari, Italy, a.giustina@libero.it. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: EuroQol (EQ-5D) health utility scores for patients with migraine.
Next Document: MicroRNA profile indicates downregulation of the TGF? pathway in sporadic non-functioning pituitary ...